Related references
Note: Only part of the references are listed.Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy
Stephen Lynn et al.
NEUROMUSCULAR DISORDERS (2015)
The emperor's new dystrophin: finding sense in the noise
S. D. Wilton et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Questions about efficacy of exon-skipping therapy for duchenne muscular dystrophy
Annapurna Poduri et al.
ANNALS OF NEUROLOGY (2014)
Expectations and experiences of investigators and parents involved in a clinical trial for Duchenne/Becker muscular dystrophy
Holly L. Peay et al.
CLINICAL TRIALS (2014)
Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy
J. C. van den Bergen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
Thomas Voit et al.
LANCET NEUROLOGY (2014)
ATALUREN TREATMENT OF PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY
Katharine Bushby et al.
MUSCLE & NERVE (2014)
A 19-year-old ambulant Duchenne patient with stunted growth on long-term corticosteroids
Luciano Merlini
NEUROMUSCULAR DISORDERS (2014)
Dystrophin as a therapeutic biomarker: Are we ignoring data from the past?
Steve D. Wilton et al.
NEUROMUSCULAR DISORDERS (2014)
Exon-Skipping Therapy: A Roadblock, Detour, or Bump in the Road?
Eric P. Hoffman et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
What Can We Learn From Clinical Trials of Exon Skipping for DMD?
Qi-long Lu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Eteplirsen for the Treatment of Duchenne Muscular Dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2013)
Glucocorticoid Treatment for the Prevention of Scoliosis in Children with Duchenne Muscular Dystrophy: Long-Term Follow-up
David E. Lebel et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2013)
Melanocytes-A novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy
Camilla Pellegrini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy
Jerry R. Mendell et al.
MUSCLE & NERVE (2013)
The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures
Erik K. Henricson et al.
MUSCLE & NERVE (2013)
Doubts raised over 'read-through' Duchenne drug mechanism
Cormac Sheridan
NATURE BIOTECHNOLOGY (2013)
Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network
Anne M. Connolly et al.
NEUROMUSCULAR DISORDERS (2013)
Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
Richard S. Finkel et al.
PLOS ONE (2013)
Early corticosteroid treatment in 4 duchenne muscular dystrophy patients: 14-year follow-up
Luciano Merlini et al.
MUSCLE & NERVE (2012)
Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens
L. E. Taylor et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials
Karen Anthony et al.
BRAIN (2011)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
Duchenne muscular dystrophy: Survival by cardio-respiratory interventions
Yuka Ishikawa et al.
NEUROMUSCULAR DISORDERS (2011)
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Nathalie M. Goemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Comparison of motor strength and function in patients with Duchenne muscular dystrophy with or without steroid therapy
Samara Lamounier Santana Parreira et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2010)
Change in Natural History of Duchenne Muscular Dystrophy With Long-term Corticosteroid Treatment: Implications for Management
Richard T. Moxley et al.
JOURNAL OF CHILD NEUROLOGY (2010)
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
Katharine Bushby et al.
LANCET NEUROLOGY (2010)
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
Katharine Bushby et al.
LANCET NEUROLOGY (2010)
Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients
A. T. J. M. Helderman-van den Enden et al.
NEUROMUSCULAR DISORDERS (2010)
Immunohistological intensity measurements as a tool to assess sarcolemma-associated protein expression
V. Arechavala-Gomeza et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. (vol 8, pg 918, 2009)
M. Kinali et al.
LANCET NEUROLOGY (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali et al.
LANCET NEUROLOGY (2009)
Deflazacort use in Duchenne muscular dystrophy:: An 8-year follow-up
Sylvie Houde et al.
PEDIATRIC NEUROLOGY (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy
W. M. King et al.
NEUROLOGY (2007)
Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy
Ameet S. Daftary et al.
PEDIATRICS (2007)
Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade
WD Biggar et al.
NEUROMUSCULAR DISORDERS (2006)
Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy - Long-term effect
B Balaban et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2005)
Early prednisone treatment in Duchenne muscular dystrophy
L Merlini et al.
MUSCLE & NERVE (2003)
High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy
AM Connolly et al.
NEUROMUSCULAR DISORDERS (2002)
Preserving function in Duchenne dystrophy with long-term pulse prednisone therapy
GT Carter et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2000)
Share Paper
